Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions
Must Reads by Date
Must reads for theWeek ending September 3, 2017
Cochrane on Cancer Testing in People with VTE, Cochrane; 2017 Aug 23; Robertson, Yeoh, et al
Vitamin D Insufficiency and FL Outcomes, Blood Cancer J; ePub 2017 Aug 25; Tracy, et al
HCT Impact on Utilization in Sickle Cell Disease, Haematologica; ePub 2017 Aug 17; Arnold, et al
Impact of Fluid Overload on HSCT Outcomes, Biol Blood Marrow Transplant; ePub 2017 Aug 24; Rondón, et al
Does This Mutation Affect DLBCL Outcomes?, Biol Blood Marrow Transplant; ePub 2017 Aug 25; Lee, et al
Must reads for theWeek ending August 27, 2017
Economic Burden of Multiple Myeloma Evaluated, Leuk Lymphoma; ePub 2017 Aug 13; MacEwan, et al
Use CNS Prophylaxis Selectively in These Patients, Am J Hematol; ePub 2017 Aug 17; Malecek, et al
Survey Reveals Unmet Needs in HCT Survivors, Biol Blood Marrow Transplant; ePub 2017 Aug 4; Hahn, et al
Immunosuppression Discontinuation in Chronic GVHD, Biol Blood Marrow Transplant; ePub 2017 Aug 7; Curtis, et al
Besponsa Approved for Certain Type of ALL, FDA news release; 2017 Aug 17
Must reads for theWeek ending August 20, 2017
Guideline on HCT for Certain Lymphoma Types, Biol Blood Marrow Transplant; ePub 2017 Aug 7; Kharfan-Dabaja, et al
Weekend vs Weekday Leukemia Admissions, Clin Lymphoma Myeloma Leuk; ePub 2017 Aug 8; Parikh, et al
Health Care Use in People with AML at End of Life, J Clin Oncol; ePub 2017 Aug 7; Wang, Zeidan, et al
MCL in First Remission: Does Imaging Matter?, Leuk Lymphoma; ePub 2017 Aug 10; Guidot, et al
Cognitive Function After Allogeneic HCT Evaluated, Biol Blood Marrow Transplant; ePub 2017 Aug 7; Hoogland, et al
Must reads for theWeek ending August 13, 2017
Platelet Refractoriness in Hematologic Disorders, Cochrane; 2017 Jul 30; Estcourt, Malouf, et al
Substantial Contributor to Pediatric NHL Burden, Cancer; ePub 2017 Jul 31; Yanik, Shiels, et al
FDA Approves Imbruvica for Chronic GVHD, FDA news release; 2017 Aug 2
Idhifa Approved for Certain Patients with AML, FDA news release; 2017 Aug 1
FDA Approves Vyxeos for 2 Types of AML, FDA news release; 2017 Aug 3
Must reads for theWeek ending August 6, 2017
Sepsis Incidence in Patients with AML Evaluated, Clin Lymphoma Myeloma Leuk; ePub 2017 Jul 25; Malik, et al
Lenalidomide After ASCT for Multiple Myeloma, J Clin Oncol; ePub 2017 Jul 25; McCarthy, et al
Algorithm for Heparin-Induced Thrombocytopenia, J Thromb Haemost; ePub 2017 Jul 17; Raschke, et al
Outcomes in Patients with MYC-Positive DLBCL, Cancer; ePub 2017 Jul 27; Epperla, Maddocks, et al
Toxicity and Mortality in Older AHCT Recipients, Am J Hematol; ePub 2017 Jul 19; Belete, et al